Harper; Bart
Patent Applications and Registrations
Patent applications and USPTO patent grants for Harper; Bart.The latest application filed is for "factor xia inhibitors".
- Harper; Bart - New York NY US
| Patent | Date |
|---|---|
| Factor IXa inhibitors Grant 10,351,558 - Meng , et al. July 16, 2 | 2019-07-16 |
| Pyrimidinone amide compounds as PDE2 inhibitors Grant 10,285,989 - Shen , et al. | 2019-05-14 |
| Factor XIA inhibitors Grant 10,214,512 - Xu , et al. Feb | 2019-02-26 |
| Factor Xia Inhibitors App 20180339977 - Xu; Jiayi ; et al. | 2018-11-29 |
| Pyrimidinone Amide Compounds As Pde2 Inhibitors App 20180256575 - Shen; Dong-Ming ; et al. | 2018-09-13 |
| Isoquinoline derivatives as MGAT2 inhibitors Grant 10,065,945 - Berger , et al. September 4, 2 | 2018-09-04 |
| Factor IXa Inhibitors App 20180022747 - Meng; Dongfang ; et al. | 2018-01-25 |
| Isoquinoline Derivatives As Mgat2 Inhibitors App 20180009796 - Berger; Richard ; et al. | 2018-01-11 |
| Pyrimidone carboxamide compounds as PDE2 inhibitors Grant 9,815,796 - Shen , et al. November 14, 2 | 2017-11-14 |
| Pyrimidone Carboxamide Compounds As Pde2 Inhibitors App 20170015633 - Shen; Dong Ming ; et al. | 2017-01-19 |
| Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists Grant 8,501,786 - Berger , et al. August 6, 2 | 2013-08-06 |
| Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,354,403 - Edmondson , et al. January 15, 2 | 2013-01-15 |
| Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120157432 - Edmondson; Scott D. ; et al. | 2012-06-21 |
| Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,884,104 - Cox , et al. February 8, 2 | 2011-02-08 |
| Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20110028461 - Berger; Richard ; et al. | 2011-02-03 |
| Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20080076773 - Cox; Jason M. ; et al. | 2008-03-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 